Status | Study |
RECRUITING |
Study Name: Effects of Pazopanib on Hereditary Hemorrhagic Telangiectasia Related Epistaxis and Anemia (Paz) Condition: Hereditary Hemorrhagic Telangiectasia Date: 2019-02-12 Interventions: gel capsule, with 25mg-similar fills |
Recruiting |
Study Name: MRA With Feraheme in HHT Condition: Hereditary Hemorrhagic Telangiectasia Date: 2016-11-28 Interventions: Procedure: Feraheme MRI/MRA Other Name: Ferumoxytol |
Recruiting |
Study Name: Graded TTCE for Post-Embolization PAVM Monitoring Condition: Hereditary Hemorrhagic Telangiectasia (HHT) Date: 2016-10-10 Interventions: Other: Transthoracic Contrast Echocardiogram A transthoracic contrast echocardiogram (TTCE) is a still o |
Not yet recruiting |
Study Name: Treatment of Nasal Staphylococcus Aureus Colonization in Patients With HHT Condition: Hereditary Hemorrhagic Telangiectasia Epistaxis Date: 2016-08-09 Interventions: Drug: Mupirocin Mupirocin oint |
Recruiting |
Study Name: Symptoms and Treatment Results in Hereditary Hemorrhagic Telangiectasia Condition: Hereditary Haemorrhagic Telangiectasia (HHT) Date: 2016-02-09 Interventions: Other: questionnaire a questionnaire based study |
Recruiting |
Study Name: Prospective Pilot Study of Floseal for the Treatment of Anterior Epistaxis in Patients With (HHT) Condition: Hereditary Hemorrhagic Telangiectasia (HHT) Epistaxis Date: 2015-10-13 Interventions: Drug: Floseal Topical lidocain |
Withdrawn |
Study Name: Pomalidomide in Hereditary Hemorrhagic Telangiectasia and Transfusion-Dependent Vascular Ectasia: a Phase I Study Condition: Hereditary Hemorrhagic Telangiectasia Idiopathic Vascular Ectas Date: 2014-11-06 Interventions: Drug: Pomalidomide Other Names: Pomalyst CC-4047 Imno |
Terminated |
Study Name: Efficacy of a Bevacizumab Nasal Spray as a Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) Condition: Hereditary Hemorrhagic Telangiectasia Epistaxis Date: 2014-04-01 Interventions: Drug: Bevacizumab Other Name: |
Recruiting |
Study Name: Iron Deficiency and Hereditary Haemorrhagic Telangiectasia Condition: Hereditary Haemorrhagic Telangiectasia Date: 2013-07-23 Interventions: Drug: Ferrous sulphate 200mg oral tablet Administration by mouth |
Recruiting |
Study Name: Topical Anti-angiogenic Therapy for Telangiectasia in HHT: Proof of Concept Condition: Hereditary Hemorrhagic Telangiectasia Date: 2012-12-14 Interventions: Drug: Topical timolol maleate |